Bafna Pharmaceuticals standalone net profit rises 395.83% in the September 2021 quarter
Sales rise 87.11% to Rs 28.44 crore
Net profit of Bafna Pharmaceuticals rose 395.83% to Rs 2.38 crore in the quarter ended September 2021 as against Rs 0.48 crore during the previous quarter ended September 2020. Sales rose 87.11% to Rs 28.44 crore in the quarter ended September 2021 as against Rs 15.20 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales28.4415.20 87 OPM %20.048.42 -PBDT5.771.49 287 PBT4.350.48 806 NP2.380.48 396Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 12 2021 | 4:28 PM IST